iSpeak Blog

Flexibility in Facility Design and Delivery

Flexibility in Facility Design and Delivery - Genentech hall Interior

In recent years pharmaceutical manufacturers have responded to increased demands for speed to market, rapid drug development, and increased manufacturing capacities with innovative approaches to adapt to quickly shifting global needs. The design and construction of pharmaceutical facilities has evolved as companies identify ways to prepare new and existing facilities for future needs and challenges. Join us at the 2024 ISPE Facilities of the Future Conference to learn how companies are taking a flexible approach to facility design.

2024 ISPE Facilities of the Future Conference

NIH Center for Alzheimer’s Research on Speed to Open

Mitchell Taragin, Project Officer at the National Institute of Health (NIH) and Matt Frazier, Project Manager at Hensel Phelps, will share the NIH’s journey as an urgent need to support the National Institute of Aging and its Alzheimer’s Disease and Related Dementias research prompted the innovative design of a state-of-the-art facility, constructed with pre-manufactured modular units. Gain insights from lessons learned from the applied design-build delivery method; the modular design, out-of-state construction, and on-site installation; and the project’s experience building within NIH Design Requirement Manual guidelines.

A Flexible & Future Proof cGMP Facility for the Unknown

Joseph M. Miller, Sr. Principal Architect at Genentech, and Sal Ceja, Principal, Architect, AIA, LEED AP at EwingCole, will highlight a newly constructed Roche Cell & Gene Therapy network facility designed to be a flexible and future proof cGMP facility in Hillsboro, OR, USA. Learn about the challenges of designing a facility for unknown products and future expansion and flexibility and engage with presenters as they explore the many product and test fit studies which were carried out.

Rapid Drug Substance Facility End 2 End Modular Delivery

Peter Fischer, Sales Director at Exyte Management GmbH, will be joined by Thomas Kastenberger and Guido Seidel, Wacker Chemie AG, to share the company’s need to increase capacity with an expeditious timeline. Review project schedules and critical requirements and milestones with them and hear how the issues were addressed with modular design, plug and play equipment, and emerging technologies.

Designing a Gene Therapy Factory that Flexes for the Future

Accompanied by Curt Biehn, Director of Life Sciences Solutions at Jacobs Engineering Group Inc., Stephen Marr, Head of Real Estate at of Spark Therapeutics, Facilities and Capital Programs and Christine Sheaffer, Head of Manufacturing & Supply at Spark Therapeutics, Inc. will present the unique challenges in the design and ongoing construction of one of the world’s largest new gene therapy manufacturing facilities in Philadelphia, PA, USA. Interact with presenters as they share the lessons learned from their experience in designing a flexible, multi-use, self-contained facility while engaging the local community to ensure a positive local impact.

Register for the 2024 ISPE Facilities of the Future Conference to learn from industry leaders as they share their real-world experience in these and other aspects of Facility Design and Delivery.

Learn More & Register